Document is current

Article History

Received: 19 November 2023

Accepted: 23 April 2024

First Online: 2 May 2024

Declarations

:

: This study was approved as part of the Diagnostic Accelerator clinical trial, by the Oxford University Clinical Trials Research Ethics Committee (OxTREC number 52 − 19) and Nepal Health Research Council (NHRC) (Reference number 2062) in Nepal. Participants (patients or caregivers and HCWs) provided written consent after they were informed about the study.

: Not applicable.

: SU, BS, SS, AD, AK, AG, BB, OSa, and PO declare that they have no competing interests. OBC worked as a consultant for the FIND project and received a consultancy fee for their involvement from PAHS and Oxford University Clinical Research Unit (OUCRU). SP worked as a Research Assistant. OSh worked as a consultant with Oxford University Clinical Research Unit (OUCRU) and received consultancy fees. JN was employed by FIND, the Sponsor of the study within which this work was conducted. PH was contracted by FIND to support the described study and publication. In addition, all authors have completed the ICMJE Form for Disclosure of Potential Conflicts of Interest, which have been submitted along with this manuscript.